High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Shares of Bloom Energy (NYSE:BE) have gone on a month-long tear that stands out against both the broad market and every other name in its immediate neighborhood. Bloom Energy stock is at $277.81, having gained 38% over the past month, a run big enough to make the take-profits-or-buy-more question the one worth asking on this […]
Adobe has fallen harder than its software peers while the broader market climbed, and the selling has not slowed even after quarterly results landed. The case for a bounce and the case for dead money both start with the same price chart and reach opposite conclusions.
See how these two popular ETFs stack up on risk, performance, and fees.
A stretched but firmly bullish Bitcoin chart is riding the same tailwind lifting stocks: falling oil, a record Nasdaq, and a Fed that hiked rates while quietly pumping liquidity into the system.
Of the 14 U.S.-listed companies now worth $1 trillion or more, 11 have been recommended by Team Rule Breakers or David Gardner.
VOOG targets large-cap tech giants, while IWO offers broader exposure to over 1,000 small-cap stocks. Here's how the two stack up.
Compass Therapeutics, Inc. (NASDAQ:CMPX) shares are trading lower on Tuesday as the FDA feedback raises new questions about the timing and requirements for its tovecimig program. The move is coming even as S&P 500 futures are up 0.1%, pointing to stock-specific pressure rather than a broad risk-off tape. Read Also: Compass Therapeutics' Bile Duct Cancer Drug Seen As New Standard Of Care CMPX Stock Drops After FDA Feedback On Tovecimig BLA Path Compass said the FDA recommended the company run a t
Lowe's Companies (LOW) stock trades near $191, its lowest price of the past year and about 33% below its 52-week high. Over the trailing twelve months, it lost 25.9%, while the S&P 500 returned 18.5% with dividends reinvested. No market crash did this. So how much further could it fall if one arrives.
(Updates with index/price moves, macroeconomic data, and comments from the first paragraph.) US e
Skyward Specialty Insurance has had an impressive run over the past six months as its shares have beaten the S&P 500 by 17.7%. The stock now trades at $57.18, marking a 33.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
(Updates with latest market prices and developments.) US benchmark equity indexes were mixed intr
Over the past six months, Malibu Boats’s stock price fell to $23.66. Shareholders have lost 9.9% of their capital, which is disappointing considering the S&P 500 has climbed by 16.2%. This might have investors contemplating their next move.
One key rate move sits behind the bullish forecast
Stock market crashes of 30% or more have taken anywhere from six months to 7.5 years to fully recover since 1957.
Over the last six months, S&P Global’s shares have sunk to $405.30, producing a disappointing 5.5% loss - a stark contrast to the S&P 500’s 16.2% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
The artificial-intelligence trade is ripping once again, with tech stocks cresting fresh all-time highs, Wall Street bosses touting the scale of the investment race, and key players in the ecosystem downplaying existential risks from the world’s most important technology. Comments from JPMorgan’s Jamie Dimon on AI spending, pushback from Nvidia CEO Jensen Huang on AI risks, and surge in popularity of Meta Platform new AI agent Muse have all played a role in the tech resurgence. “There were lots worrying investors last week, and there still are,” said Ed Yardeni, founder and CEO of Yardeni Research.
ACHC shares have doubled YTD as a raised 2026 outlook, stronger cash flow and new facility openings bolster its rebound.
Over the past six months, Floor And Decor’s stock price fell to $47.18. Shareholders have lost 9.9% of their capital, which is disappointing considering the S&P 500 has climbed by 16.2%. This might have investors contemplating their next move.
(Updates with index/price moves and company/geopolitical news from the first paragraph.) US equit
Dividend stocks have been hot buys this year, and the Schwab U.S. Dividend Equity ETF has risen by 22%, outperforming the broader markets.
Over the last six months, Option Care Health’s shares have sunk to $23.95, producing a disappointing 15.7% loss - a stark contrast to the S&P 500’s 16.2% gain. This might have investors contemplating their next move.
NSP's shares surge 90.9% in six months as margin recovery, PEO demand and strong liquidity offset rising health care cost pressures.
Over the last six months, BrightView’s shares have sunk to $10.66, producing a disappointing 9.3% loss - a stark contrast to the S&P 500’s 16.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
GM's shares surge 43.3% in a year as stronger earnings, tech upgrades and solid cash flow offset rising costs and macroeconomic pressure.
Mechanical selling from an index rebalance is dragging Trade Desk lower, but the way its ad-tech peers are splitting tells a more specific story about which corner of programmatic advertising the market is actually repricing right now.
Mastercard trades at $567.50 and has moved in lockstep with the market. Its shares have returned 13.4% over the last six months while the S&P 500 has gained 16.2%.
Visa (V) stock has run well ahead of the market, returning 13.5% over the past three months against 4.2% for the S&P 500. It now trades about 4% below its 52-week high. The next leg depends less on card swipes than on the services Visa sells on top of its network, which now bring in almost a third of its revenue.
Over the past six months, Merck has been a great trade, beating the S&P 500 by 13.4%. Its stock price has climbed to $149.98, representing a healthy 29.6% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
The Nasdaq Composite was up, the Dow Jones Industrial Average was down, and the S&P 500 Index was ro
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
